946 related articles for article (PubMed ID: 27682868)
1. Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial.
Priebe S; Bremner SA; Lauber C; Henderson C; Burns T
Health Technol Assess; 2016 Sep; 20(70):1-122. PubMed ID: 27682868
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial.
Priebe S; Yeeles K; Bremner S; Lauber C; Eldridge S; Ashby D; David AS; O'Connell N; Forrest A; Burns T
BMJ; 2013 Oct; 347():f5847. PubMed ID: 24100934
[TBL] [Abstract][Full Text] [Related]
3. Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT).
Priebe S; Burton A; Ashby D; Ashcroft R; Burns T; David A; Eldridge S; Firn M; Knapp M; McCabe R
BMC Psychiatry; 2009 Sep; 9():61. PubMed ID: 19785727
[TBL] [Abstract][Full Text] [Related]
4. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.
Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AF; Staring AB; Mulder CL
Lancet Psychiatry; 2017 Mar; 4(3):199-207. PubMed ID: 28236956
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial.
Henderson C; Knapp M; Yeeles K; Bremner S; Eldridge S; David AS; O'Connell N; Burns T; Priebe S
PLoS One; 2015; 10(10):e0138816. PubMed ID: 26448540
[TBL] [Abstract][Full Text] [Related]
6. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
7. Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT.
Morrison AP; Pyle M; Byrne R; Broome M; Freeman D; Johns L; James A; Husain N; Whale R; MacLennan G; Norrie J; Hudson J; Peters S; Davies L; Bowe S; Smith J; Shiers D; Joyce E; Jones W; Hollis C; Maughan D
Health Technol Assess; 2021 Jan; 25(4):1-124. PubMed ID: 33496261
[TBL] [Abstract][Full Text] [Related]
8. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
[TBL] [Abstract][Full Text] [Related]
9. The effect of financial incentives on patients' motivation for treatment: results of "Money for Medication," a randomised controlled trial.
Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
BMC Psychiatry; 2018 May; 18(1):144. PubMed ID: 29793451
[TBL] [Abstract][Full Text] [Related]
10. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
[TBL] [Abstract][Full Text] [Related]
11. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
[TBL] [Abstract][Full Text] [Related]
12. Positive behaviour support training for staff for treating challenging behaviour in people with intellectual disabilities: a cluster RCT.
Hassiotis A; Poppe M; Strydom A; Vickerstaff V; Hall I; Crabtree J; Omar R; King M; Hunter R; Bosco A; Biswas A; Ratti V; Blickwedel J; Cooper V; Howie W; Crawford M
Health Technol Assess; 2018 Mar; 22(15):1-110. PubMed ID: 29596045
[TBL] [Abstract][Full Text] [Related]
13. The effect of financial incentives on adherence to antipsychotic depot medication: does it change over time?
Pavlickova H; Bremner SA; Priebe S
J Clin Psychiatry; 2015 Aug; 76(8):e1029-34. PubMed ID: 26335089
[TBL] [Abstract][Full Text] [Related]
14. Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.
Howard R; Cort E; Bradley R; Harper E; Kelly L; Bentham P; Ritchie C; Reeves S; Fawzi W; Livingston G; Sommerlad A; Oomman S; Nazir E; Nilforooshan R; Barber R; Fox C; Macharouthu A; Ramachandra P; Pattan V; Sykes J; Curran V; Katona C; Dening T; Knapp M; Romeo R; Gray R
Health Technol Assess; 2018 Nov; 22(67):1-62. PubMed ID: 30507375
[TBL] [Abstract][Full Text] [Related]
15. Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years.
Robertson W; Fleming J; Kamal A; Hamborg T; Khan KA; Griffiths F; Stewart-Brown S; Stallard N; Petrou S; Simkiss D; Harrison E; Kim SW; Thorogood M
Health Technol Assess; 2017 Jan; 21(1):1-180. PubMed ID: 28059054
[TBL] [Abstract][Full Text] [Related]
16. CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
Bosanquet K; Adamson J; Atherton K; Bailey D; Baxter C; Beresford-Dent J; Birtwistle J; Chew-Graham C; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hamilton J; Hargate R; Hewitt C; Holmes J; Keding A; Lewis H; McMillan D; Meer S; Mitchell N; Nutbrown S; Overend K; Parrott S; Pervin J; Richards DA; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Gilbody S
Health Technol Assess; 2017 Nov; 21(67):1-252. PubMed ID: 29171379
[TBL] [Abstract][Full Text] [Related]
17. Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders.
Noordraven EL; Audier CH; Staring AB; Wierdsma AI; Blanken P; van der Hoorn BE; Roijen LH; Mulder CL
BMC Psychiatry; 2014 Dec; 14():343. PubMed ID: 25438877
[TBL] [Abstract][Full Text] [Related]
18. A feasibility randomised controlled trial of a motivational interviewing-based intervention for weight loss maintenance in adults.
Simpson SA; McNamara R; Shaw C; Kelson M; Moriarty Y; Randell E; Cohen D; Alam MF; Copeland L; Duncan D; Espinasse A; Gillespie D; Hill A; Owen-Jones E; Tapper K; Townson J; Williams S; Hood K
Health Technol Assess; 2015 Jul; 19(50):v-vi, xix-xxv, 1-378. PubMed ID: 26168409
[TBL] [Abstract][Full Text] [Related]
19. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
